Detecting and Monitoring Scoliosis Without Radiography: Standard Radiographic Monitoring Program Versus Self-Screening with Momentum SpineTM
Launched by CHILDREN'S HOSPITAL LOS ANGELES · Feb 10, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new application called Momentum SpineTM, which aims to help detect and monitor scoliosis, a condition that causes the spine to curve abnormally, in adolescents aged 8 to 18. The researchers want to see if this app can accurately track changes in the spine's curvature, particularly when the curve increases by 7 degrees or more. By using this tool, the hope is to reduce unnecessary visits to the doctor while still ensuring that any significant changes are caught in a timely manner.
To participate, children must be between 8 and 18 years old and have a confirmed diagnosis of adolescent idiopathic scoliosis, but they should not have had any spinal surgery or certain other conditions. Participants will use their personal devices to perform monthly scans at home, which will be reviewed by their healthcare provider. They will also complete a satisfaction survey after six months of using the app. It's important to note that participants must have access to a compatible smartphone and be able to communicate in English or Spanish, as the app is currently only available in those languages.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Children between the ages of 8-18 years of age
- • Confirmed radiographic diagnosis of adolescent idiopathic scoliosis
- • No history of spinal/ chest surgery.
- • Participants who have had spine x-rays ±1 week as baseline visit at CHLA will be included in the study.
- • Participants who have identifiable markings such as tattoos or birthmarks can be included in the study, though their markings will be covered with tape.
- Exclusion Criteria:
- • Participants who have had x-rays in a brace will not be included.
- • Participants who have had an x-ray from another institution will not be included in the study. X-rays from out of community are typically done with a different and lower quality machine then the one at our institution. Additionally, we do not have consent from outside institutions to use their x-rays for research purposes.
- • Participants with a confirmed pregnancy will not be included. Pregnancy status will be self-reported by participants.
- • Participants with the existence of a second deformity which may affect topographic assessment will be excluded (e.g. Limb length discrepancy greater than 2cm).
- • Families who do not speak English and Spanish will be unable to participate as the application is only available in English and Spanish at this time.
- • Families who do not have access to their own compatible personal smart phone device will be unable to participate in the study.
About Children's Hospital Los Angeles
Children's Hospital Los Angeles (CHLA) is a renowned pediatric healthcare institution dedicated to advancing the health and well-being of children through innovative research and clinical care. As a leading clinical trial sponsor, CHLA is committed to conducting high-quality, ethical research that addresses critical pediatric health issues. With a focus on translating scientific discoveries into effective treatments, CHLA collaborates with multidisciplinary teams and leverages state-of-the-art facilities to support a wide range of clinical trials. Their mission is to enhance the understanding and treatment of childhood diseases, ultimately improving outcomes for young patients and their families.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Lindsay M Andras, MD
Principal Investigator
Children's Hospital Los Angeles
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported